⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17996688 | 0.82 | — | — | |
| SCHEMBL1127617 | 0.80 | — | — | |
| SCHEMBL279487 | 0.80 | — | — | |
| SCHEMBL9577650 | 0.78 | — | — | |
| SCHEMBL772438 | 0.78 | — | — | |
| Phenol SCHEMBL10905158 | 0.76 | TDP1 (0.46) | — | |
| SCHEMBL10097915 | 0.76 | — | — | |
| SCHEMBL296293 | 0.76 | — | — | |
| SCHEMBL11624897 | 0.76 | THRB (0.46) | — | |
| SCHEMBL1392683 | 0.76 | THRB (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105473231-A | Process for the regeneration of a supported noble metal catalyst | BASF SE | 2016-04-06 | — | — | CN | claimed |
| CN-102503840-B | Preparation method of dezocine | HAICI BIOLOG PHARMACEUTICAL CO LTD OF YANGTZE RIVERS PHARMACEUTICAL GROUP | 2013-06-19 | — | — | CN | claimed |
| CN-102985456-A | Carbodiimidization method | BAYER IP GMBH | 2013-03-20 | — | — | CN | claimed |
| CN-102503840-A | Preparation method of dezocine | HAICI BIOLOG PHARMACEUTICAL CO LTD OF YANGTZE RIVERS PHARMACEUTICAL GROUP | 2012-06-20 | — | — | CN | claimed |
| CN-114805375-B | N-phenylalkoxy dibenzoazepine compound, preparation method and medical application thereof | 徐州医科大学 | 2023-07-25 | — | — | CN | disclosed |
| US-11331274-B2 | Milrinone controlled-release formulation | Baker Heart and Diabetes Institute (AU) | 2022-05-17 | — | — | US | disclosed |
| CN-107530337-B | Method of treatment | 贝克心脏与糖尿病研究所 | 2021-07-09 | — | — | CN | disclosed |
| EP-3718546-A1 | CONTROLLED-RELEASE FORMULATION | Cardiora Pty Ltd (AU) | 2020-10-07 | — | — | EP | disclosed |
| US-10736853-B2 | Milrinone controlled-release formulation | CARDIORA PTY LTD. (AU) | 2020-08-11 | — | — | US | disclosed |
| US-20200146992-A1 | MILRINONE CONTROLLED-RELEASE FORMULATION | CARDIORA PTY LTD. (AU) | 2020-05-14 | — | — | US | disclosed |
| US-20200101053-A1 | METHOD OF TREATING HEART FAILURE WITH PRESERVED EJECTION FRACTION BY ADMINISTERING MILRINONE | CARDIORA PTY LTD (AU) | 2020-04-02 | — | — | US | disclosed |
| EP-3236963-B1 | METHOD OF TREATMENT | CARDIORA PTY LTD (AU) | 2020-01-29 | — | — | EP | disclosed |
| US-7351142-B2 | Method and apparatus for facilitating play of fractional value lottery games | WALKER DIGITAL, LLC (US) | 2008-04-01 | — | — | US | disclosed |
| US-20080054707-A1 | Formation Breaking Assembly | NOVATEK IP, LLC | 2008-03-06 | — | — | US | disclosed |
| CN-1230428-C | Method for producing epoxide | BASF AG (DE) | 2005-12-07 | — | — | CN | disclosed |
| CN-1217885-C | Method for producing ketals and/or acetals | MITSUBISHI CHEM CORP (JP) | 2005-09-07 | — | — | CN | disclosed |
| CN-1494538-A | Method for producing epoxide | �����ɷ� | 2004-05-05 | — | — | CN | disclosed |
| CN-1426384-A | Method for producing ketals and/or acetals | MITSUBISHI CHEM CORP (JP) | 2003-06-25 | — | — | CN | disclosed |
| CN-1244212-A | Improved expression vectors | PROCTER & GAMBLE (US) | 2000-02-09 | — | — | CN | disclosed |
| CN-1125955-A | Microcellular polyurethane materials | ICI PLC (GB) | 1996-07-03 | — | — | CN | disclosed |